We’re proud to share an exciting milestone for the Gelomics team: we’ve officially been awarded ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications! These internationally recognized standards reflect our commitment to quality, environmental responsibility, and the health and safety of our team. The certifications were awarded on June 4, 2025, and mark a new […]
At Gelomics, we are committed to making cutting-edge, animal-free research tools more accessible to scientists around the globe. Today, we’re excited to announce a new strategic partnership with Morpho Biotech, who will serve as the exclusive distributor of Gelomics products in the Netherlands, Belgium, and Luxembourg (Benelux) starting July 1st, 2025. Morpho Biotech is a […]
We’re excited to announce that Gelomics is now a registered supplier on BioNordika! Our cutting-edge 3D cell culture technologies are now accessible to researchers across the Nordic and Baltic regions. BioNordika is a trusted distributor representing a wide range of world-leading and innovative life science suppliers. Their portfolio includes comprehensive workflow solutions in immunology, diagnostics, […]
Gelomics, a pioneering Australian biotech firm redefining the future of drug development with its cutting-edge 3D tissue culture technologies, is delighted to announce the appointment of Distinguished Professor Gail Risbridger AM to its Scientific Advisory Board. Professor Risbridger joins a team of internationally recognized scientific leaders, bringing a wealth of expertise in translational research […]
Gelomics is proud to announce a strategic distribution partnership with Scientific Laboratory Supplies (SLS), the United Kingdom’s largest independent supplier of laboratory products. Under this agreement, SLS will serve as Gelomics’ exclusive distributor in the UK and Ireland, significantly expanding access to our advanced 3D tissue culture systems for researchers across the region. Empowering Researchers […]
We are excited to announce that Gelomics is now a supplier on Scientist.com! Through this leading platform for scientific sourcing, we are providing simple, fast and reliable access to our innovative 3D tissue culture products and services in the US. Why choose Gelomics on Scientist.com? Since 2007, Scientist.com has become a trusted supplier for the […]
Gelomics proudly announces a strategic partnership with Voden Medical. Voden Medical is a renowned provider of advanced diagnostic and life science solutions in Italy. Under this agreement, Voden Medical will serve as Gelomics’ exclusive distributor in the Italian market. This partnership, effective January 2025, marks a significant step forward in Gelomics’ mission to bring our […]
Gelomics is pleased to announce a new strategic partnership with Bucher Biotec AG, a leading provider of advanced life science solutions in Switzerland & Lichtenstein. Under this agreement, Bucher Biotec will serve as Gelomics’ exclusive distributor across the Swiss market. This partnership marks an important milestone for Gelomics as we expand our presence in Europe. […]
Gelomics, a leading Australian biotech firm at the forefront of drug development innovation, is further strengthening its Scientific Advisory Board with the addition of Distinguished Professor Dietmar W. Hutmacher, PhD, MBA, and Professor Travis J. Klein, PhD. Following the recent appointment of Professor Dame Molly Stevens, FREng FRS, these new appointments reinforce our commitment to […]
We’re thrilled to unveil our latest innovation! LunaGel™ Ultrapure GelMA Photocrosslinkable Extracellular Matrix (ECM), now available in both High Stiffness and Low Stiffness options. Developed in collaboration with Rousselot Biomedical, this breakthrough leverages the advanced X-Pure® GelMA technology, setting a new standard for 3D cell culture by offering unparalleled control over matrix porosity and stiffness. […]
+61 1800 865 060
Send us an email here
60 Musk Avenue
Kelvin Grove, QLD 4059
Australia
ABN 14 624 623 623
